✦ LIBER ✦

S2-04-06: Safety, tolerability and immunogenicity of the Aβ immunotherapeutic vaccine CAD106 in a first-in-man study in Alzheimer patients

✍ Scribed by Bengt Winblad

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of the first-in-man study with t

✍ Bengt G. Winblad; L. Minthon; A. Floesser; G. Imbert; T. Dumortier; Y. He; P. Ma 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Safety, tolerability, and antibody respo

✍ Bengt Winblad; Niels Andreasen; Lennart Minthon; Annette Floesser; Georges Imber 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 606 KB

Immunogenicity, safety and tolerability

✍ Susanna Esposito; Emanuela D’Angelo; Cristina Daleno; Francesco Peia; Alessia Sc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Safety, tolerability and immunogenicity

✍ Arai, Heii; Suzuki, Hideo; Yoshiyama, Tamotsu; Lobello, Kasia; Peng, Yahong; Liu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A PHASE I/IIA FIRST IN MAN SAFETY AND TO

✍ Doug Cowart; Juan Aranda; Garrie Haas; Joel Neutel; William Smith; Reza Mazhari; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Immunogenicity and safety of the bivalen

✍ Heijstek, M. W.; Scherpenisse, M.; Groot, N.; Tacke, C.; Schepp, R. M.; Buisman, 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 622 KB